The transaction included a circa €520 million debt reduction and an injection of new capital of circa €71 million alongside meaningful maturity extensions. The transaction was fully consensual following the consent solicitation launched by Oriflame Investment Holding Plc in November 2025 and delivers a de-leveraged and sustainable balance sheet to support Oriflame’s long term future.
Partner Andrew Weaver led the team, assisted by counsel Daniel Healy and associates Inyene Udoh and Larissa Dezyk (corporate and finance) and supported by partner Sam Williams and senior associate Lara von Wildenrath (restructuring and disputes).
Andrew said: “We were delighted to support this transaction to give Oriflame a stronger footing for the future. This is a fantastic example of Appleby experts working across legal areas to showcase our experience on advising on complex restructuring transactions of this nature.”
Oriflame is a global beauty and wellbeing company founded in Sweden, operating in over 60 markets through a modern social selling model. Its portfolio spans skincare, cosmetics, fragrances, and personal care.
Appleby has significant experience advising on complex restructuring transactions of this nature.
